While foreign investors have been tied up with Chinas banks, the takeover deal of Harbin Pharmaceutical Holding Group suggests inteational buyout funds are at the same time looking for opportunities in different areas. An investor group led by New York-based Warburg Pincus LLC last year bought a 55 percent stake in the drug maker based in northeaste Chinas Heilongjiang Province last year.